Related Experiment Video

Updated: Jul 10, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR

Maha Ayyoub1, Charles S Hesdorffer, Monica Montes

  • 1Ludwig Institute Clinical Trial Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

The Journal of Clinical Investigation
|April 16, 2004
PubMed

Insights

Researchers identified a key SSX-2 protein region (37-58) that triggers CD4(+) T cell responses in melanoma patients. This finding is crucial for developing targeted cancer vaccines and monitoring treatment efficacy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Ectopic gene expression in tumors enables targeted cancer immunotherapy.
  • SSX gene products are tumor-associated antigens recognized by cytotoxic T lymphocytes (CTLs).

Purpose of the Study:

  • To identify novel SSX-2-derived T cell epitopes for cancer immunotherapy.
  • To characterize CD4(+) T cell responses to SSX antigens in melanoma patients.

Main Methods:

  • Epitope mapping of SSX-2 protein.
  • T cell epitope identification using HLA-DR association.
  • Detection of SSX-2(37-58)-specific CD4(+) T cells in patient blood and tumor samples.

Main Results:

  • An immunodominant SSX-2-derived CD4(+) T cell epitope, SSX-2(37-58), was identified.
  • This epitope is recognized in association with HLA-DR.
  • SSX-2(37-58)-specific CD4(+) T cells were prevalent in melanoma patients' circulating and tumor-infiltrating lymphocytes, but absent in healthy donors.

Conclusions:

  • The SSX-2(37-58) sequence plays a dominant role in inducing CD4(+) T cell responses against SSX antigens.
  • This epitope is a promising target for cancer vaccine development and monitoring in melanoma.
  • The findings support the use of SSX-derived immunogens in future cancer vaccine trials.

More Related Videos

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...